Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy

Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy

Abstract The reported frequency and types of adverse events following initial vaccination and revaccination with Bacille Calmette-Guérin (BCG) varies worldwide. Using active surveillance in a randomised controlled trial of BCG vaccination (the BRACE trial), we determined the incidence and risk facto...

Descrizione completa

Dettagli Bibliografici
Autori principali: Paola Villanueva, Ushma Wadia, Nigel Crawford, Nicole L. Messina, Tobias R. Kollmann, Michaela Lucas, Laurens Manning, Peter Richmond, Laure F. Pittet, Nigel Curtis
Natura: Articolo
Lingua:English
Pubblicazione: Nature Portfolio 2022-01-01
Serie:npj Vaccines
Accesso online:https://doi.org/10.1038/s41541-021-00421-5

Accesso online

https://doi.org/10.1038/s41541-021-00421-5

Documenti analoghi